An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT00487539 · COMPLETED
Trial details
- NCT number
- NCT00487539
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-10-01
- Enrollment
- 1065
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.